Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method

International Dairy Journal

Volumn 17, Issue 9, 2007, Pages 1123-1131

  Mättö, Jaana ^a   van Hoek, Angela H A M ^b   Domig, Konrad J ^c   Saarela, Maria ^a   Floréz, Ana Belén ^d   Brockmann, Elke ^e   Amtmann, Ernst ^c   Mayo, Baltasar ^d   Aarts, Henk J M ^b   Danielsen, Morten ^e  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^d DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^e Chr Hansen ^*  (Denmark)

Author keywords

Antimicrobial susceptibility; Bifidobacterium; Human intestinal; Probiotic; Tetracycline

Indexed keywords

AMINO ACIDS; ANTIBIOTICS; BACTERIA; DAIRY PRODUCTS;

ANTIMICROBIAL SUSCEPTIBILITY; BIFIDOBACTERIUM; ETEST METHOD; TETRACYCLINE;

CELL CULTURE;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM;

EID: 34249978132     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2007.01.008     Document Type: Article

References (30)

1. Aarestrup F.M., Agerso Y., Gerner-Smidt P., Madsen M., and Jensen L.B. Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark. Diagnostic Microbiology and Infectious Disease 37 (2000) 127-137
2. Aminov R.I., Garrigues-Jeanjean N., and Mackie R.I. Molecular ecology of tetracycline resistance: Development and validation of primers for detection of tetracycline resistance genes encoding ribosomal protection proteins. Applied and Environmental Microbiology 67 (2001) 22-32
3. Charteris W.P., Kelly P.M., Morelli L., and Collins J.K. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract. Letters in Applied Microbiology 26 (1998) 333-337
4. Delgado S., Florez A.B., and Mayo B. Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract. Current Microbiology 50 (2005) 202-207
5. FEEDAP Panel. Opinion of the scientific panel on additives and products or substances used in animal feed on the updating of the criteria used in the assessment of bacteria for resistance to antibiotics of human or veterinary importance. EFSA Journal 223 (2005) 1-12
6. Gavini F., Pourcher A.-M., Neut C., Monget D., Romond C., Oger C., et al. Phenotypic differentiation of bifidobacteria of human and animal origins. International Journal of Systematic Bacteriology 41 (1991) 548-557
7. Kastner S., Perreten V., Bleurer H., Hugenscmidt G., Lacroix C., and Meile L. Antibiotic susceptibility patterns and resistance genes of starter cultures and probiotic bacteria used in food. Systematic and Applied Microbiology 29 (2006) 145-155
8. Kheadr L.M., Bernoussi N., Lacroix C., and Fliss I. Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. International Dairy Journal 14 (2004) 1041-1053
9. Klare I., Konstabel C., Müller-Bertling S., Reissbrodt R., Huys G., Vancanneyt M., et al. Evaluation of new broth media for microdilution antibiotic susceptibility testing of lactobacilli, lactococci, pediococci, and bifidobacteria. Applied and Environmental Microbiology 71 (2005) 8982-8986
10. Lim K.S., Huh C.S., and Baek Y.J. Antibiotic susceptibility of bifidobacteria. Journal of Dairy Science 76 (1993) 2168-2174
11. Luna V.A., Coates P., Eady A.E., Cove J.H., Nguyen T.T.H., and Roberts M. A variety of gram-positive bacteria carry mobile mef genes. Journal of Antimicrobial Chemotherapy 44 (1999) 19-25
12. Masco L., Huys G., de Brandt E., Temmerman R., and Swings J. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. International Journal of Food Microbiology 102 (2005) 221-230
13. Masco L., Van Hoorde K., De Brandt E., Swings J., and Huys G. Antimicrobial sysceptibility of Bifidobacterium strains from humans, animals and probiotic products. Journal of Antimicrobial Chemotherapy 58 (2006) 85-94
14. Matsuki T., Watanabe K., Tanaka R., Fukuda M., and Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Applied and Environmental Microbiology 65 (1999) 4506-4512
15. Matsuki T., Watanabe K., Tanaka R., and Oyaizu H. Rapid identification of human intestinal bifidobacteria by 16S rRNA-targeted species- and group-specific primers. FEMS Microbiology Letters 167 (1998) 113-121
16. Matteuzzi D., Crociani F., and Brigidi P. Antimicrobial susceptibility of Bifidobacterium. Annales de Microbiologie (Paris) 134A (1983) 339-349
17. Mättö J., Malinen E., Suihko M.-L., Alander M., Palva A., and Saarela M. Genetic heterogeneity and technological properties of intestinal bifidobacteria. Journal of Applied Microbiology 97 (2004) 459-470
18. Mättö J., Suihko M.-L., and Saarela M. Comparison of three test media for the antimicrobial susceptibility testing of bifidobacteria with the Etest method. International Journal of Antimicrobial Agents 28 (2006) 42-48
19. Moubareck C., Gavini F., Vaugien L., Butel M.J., and Doucet-Populaire F. Antimicrobial susceptibility of bifidobacteria. Journal of Antimicrobial Chemotherapy 55 (2005) 38-44
20. NCCLS (2004). Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria: Approved Standard (6th ed.). M11-A6, Vol. 24(2), Pennsylvania, USA: Wayne (ISBN 1-56238-517-8).
21. Roe D.E., Finegold S.M., Citron D.M., Goldstein E.J.C., Wexler H.M., Rosenblatt J.E., et al. Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media. Clinical Infectious Dieases 35 Suppl 1 (2002) S40-S46
22. Roy D., and Sirois S. Molecular differentiation of Bifidobacterium species with amplified ribosomal DNA restriction analysis and alignment of short regions of the ldh gene. FEMS Microbiology Letters 191 (2000) 17-24
23. Saarela M., Mättö J., and Mattila-Sandholm T. Safety aspects of Lactobacillus and Bifidobacterium species originating from human oro-gastrointestinal tract or from probiotic products. Microbial Ecology in Health and Disease 14 (2002) 233-240
24. Saarela M., Mogensen G., Fondén R., Mättö J., and Mattila-Sandholm T. Probiotic bacteria: Safety, functional and technological properties. Journal of Biotechnology 84 (2000) 197-215
25. Scott K.P., Melville C.M., Barbosa T.M., and Flint H.J. Occurrence of the new tetracycline resistance gene tet(W) in bacteria from the human gut. Antimicrobial Agents and Chemotherapy 44 (2000) 775-777
26. Temmerman R., Pot B., Huys G., and Swings J. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. International Journal of Food Microbiology 81 (2003) 1-10
27. Teuber M., Meile L., and Schwarz F. Acquired antibiotic resistance in lactic acid bacteria from food. Antonie Van Leeuwenhoek 76 (1999) 115-137
28. van Hoek A.H.A.M., Scholtens I.M.J., Cloeckaert A., and Aarts H.J.M. Detection of antibiotic resistance genes in different Salmonella serovars by oligonucleotide microarray analysis. Journal of Microbiological Methods 62 (2005) 13-23
29. Ventura M., and Zink R. Rapid identification, differentiation, and proposed new taxonomic classification of Bifidobacterium lactis. Applied and Environmental Microbiology 68 (2002) 6429-6434
30. von Wright A. Regulating safety of probiotics-The European approach. Current Pharmaceutical Design 11 (2005) 17-23